Showing results (491-500 of 520) with videos related to

Sort By:
Pageof 52
Archives of Gerontology and Geriatrics|March 29, 2022
The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individualsA R M Saifuddin Ekram, Robyn L Woods, Joanne Ryan, et al.
Gastro Hep Advances|January 29, 2025
A Nonrandomized Pilot Study to Investigate the Acceptability and Feasibility of LivR Well: A Multifaceted 28-Day Home-Based Liver Optimization Program for Acute-on-Chronic Liver FailureNatalie L Y Ngu, Edward Saxby, Thomas Worland, et al.
ANZ Journal of Surgery|June 2, 2023
The Adelaide Score: An artificial intelligence measure of readiness for discharge after general surgeryJoshua G Kovoor, Stephen Bacchi, Aashray K Gupta, et al.
The American Journal of Cardiology|July 16, 2005
Usefulness of tissue doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study)Richard W Troughton, David L Prior, Christopher M Frampton, et al.
Emergency Medicine Journal : EMJ|April 27, 2022
Impact of prehospital opioid dose on angiographic and clinical outcomes in acute coronary syndromesHimawan Fernando, Ziad Nehme, Diem Dinh, et al.
Cardiovascular Ultrasound|May 30, 2020
Incremental prognostic value of echocardiography of left ventricular remodeling and diastolic function in STICH trialKyung-Hee Kim, Lilin She, Kerry L Lee, et al.
Research in Social & Administrative Pharmacy : RSAP|April 7, 2018
Chronic pain medication management of older populations: Key points from a national conference and innovative opportunities for pharmacy practiceJulia Fiona-Maree Gilmartin-Thomas, J Simon Bell, Danny Liew, et al.
BMJ Open|July 19, 2018
GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practiceJohn Furler, David Norman O'Neal, Jane Speight, et al.
Neurology|March 11, 2014
Fingolimod after natalizumab and the risk of short-term relapseVilija G Jokubaitis, Vivien Li, Tomas Kalincik, et al.
BMJ Open|July 2, 2021
Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocolBonita Gu, Michael De Gregorio, Joseph Louis Pipicella, et al.
Pageof 52